Prediction of age-related macular degeneration in the general population: The three continent AMD consortium

Ophthalmology

Volumn 120, Issue 12, 2013, Pages 2644-2655

  Buitendijk, Gabriëlle H S ^a   Rochtchina, Elena ^b   Myers, Chelsea ^c   Van Duijn, Cornelia M ^a   Lee, Kristine E ^c   Klein, Barbara E K ^c   Meuer, Stacy M ^c   De Jong, Paulus T V M ^d,e,f   Holliday, Elizabeth G ^g   Tan, Ava G ^b   Uitterlinden, André G ^a,h   Sivakumaran, Theru S ^i,j   Attia, John ^g,k   Hofman, Albert ^a,h   Mitchell, Paul ^b   Vingerling, Johannes R ^a   Iyengar, Sudha K ^j   Janssens, A Cecile J W ^a,l   Wang, Jie Jin ^b,m   Klein, Ronald ^c   Klaver, Caroline C W ^a   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF NEWCASTLE   (Australia)

^h NETHERLANDS GENOMICS INITIATIVE   (Netherlands)

ⁱ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^j CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^l EMORY UNIVERSITY   (United States)

^m UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALLELE; ARTICLE; BODY MASS; CLINICAL FEATURE; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; AUSTRALIA; COHORT ANALYSIS; GENE EXPRESSION PROFILING; GENETICS; GENOTYPING TECHNIQUE; INCIDENCE; MACULAR DEGENERATION; MIDDLE AGED; NETHERLANDS; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STATISTICAL MODEL; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AUSTRALIA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENOTYPING TECHNIQUES; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; MODELS, STATISTICAL; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; ROC CURVE; UNITED STATES;

EID: 84888010330     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.07.053     Document Type: Article

References (49)

1. Eye Diseases Prevalence Research Group Causes and prevalence of visual impairment among adults in the United States Arch Ophthalmol 122 2004 477 485
2. C.C. Klaver, R.C. Wolfs, and J.R. Vingerling Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study Arch Ophthalmol 116 1998 653 658
3. C.A. Augood, J.R. Vingerling, and P.T. de Jong Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE) Arch Ophthalmol 124 2006 529 535
4. World Health Organization. VISION 2020: The Right to Sight, the global initiative for the elimination of avoidable blindness: magnitude and causes of visual impairment. Fact Sheet no. 282. November 2004. Available at: http://whqlibdoc.who.int/fact-sheet/2004/FS-282.pdf. Accessed July 28, 2013.
5. R. van Leeuwen, C.C. Klaver, and J.R. Vingerling Epidemiology of age-related maculopathy: a review Eur J Epidemiol 18 2003 845 854
6. C.C. Klaver, J.J. Assink, and J.R. Vingerling Smoking is also associated with age-related macular degeneration in persons aged 85 years and older: the Rotterdam Study [letter] Arch Ophthalmol 115 1997 945
7. J.M. Seddon, U.A. Ajani, and B.D. Mitchell Familial aggregation of age-related maculopathy Am J Ophthalmol 123 1997 199 206
8. D.D. Despriet, C.C. Klaver, and J.C. Witteman Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration JAMA 296 2006 301 309
9. L. Ho, R. van Leeuwen, and J.C. Witteman Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study Arch Ophthalmol 129 2011 758 766
10. R. van Leeuwen, S. Boekhoorn, and J.R. Vingerling Dietary intake of antioxidants and risk of age-related macular degeneration JAMA 294 2005 3101 3107
11. J.R. Vingerling, A. Hofman, D.E. Grobbee, and P.T. de Jong Age-related macular degeneration and smoking. The Rotterdam Study Arch Ophthalmol 114 1996 1193 1196
12. Y. Chen, J. Zeng, and C. Zhao Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors Arch Ophthalmol 129 2011 344 351
13. J. Gibson, A. Cree, and A. Collins Determination of a gene and environment risk model for age-related macular degeneration Br J Ophthalmol 94 2010 1382 1387
14. B. Gold, J.E. Merriam, J. Zernant AMD Genetics Clinical Study Group Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration Nat Genet 38 2006 458 462
15. F. Grassmann, L.G. Fritsche, and C.N. Keilhauer Modelling the genetic risk in age-related macular degeneration PLoS One [serial online] 7 2012 e37979 Available at: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal. pone.0037979 Accessed July 28, 2013
16. G.S. Hageman, K. Gehrs, and S. Lejnine Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration Hum Genomics 5 2011 420 440
17. A.E. Hughes, N. Orr, and C. Patterson Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking PLoS Med [serial online] 4 2007 e355 Available at: http://www.plosmedicine.org/article/ info%3Adoi%2F10.1371%2Fjournal.pmed.0040355 Accessed July 28, 2013
18. J. Jakobsdottir, Y.P. Conley, and D.E. Weeks C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes PLoS One [serial online] 3 2008 e2199 Available at: http://www.plosone.org/article/ info%3Adoi%2F10.1371%2Fjournal.pone.0002199 Accessed July 28, 2013
19. J. Jakobsdottir, M.B. Gorin, and Y.P. Conley Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers PLoS Genet [serial online] 5 2009 e1000337 Available at: http://www.plosgenetics.org/article/info%3Adoi%2F10.1371%2Fjournal.pgen.1000337 Accessed July 28, 2013
20. M.L. Klein, P.J. Francis, and F.L. Ferris III Risk assessment model for development of advanced age-related macular degeneration Arch Ophthalmol 129 2011 1543 1550
21. G.J. McKay, S. Dasari, and C.C. Patterson Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort Mol Vis [serial online] 16 2010 194 199 Available at: http://www.molvis.org/molvis/v16/a24/ Accessed July 28, 2013
22. R. Reynolds, M.E. Hartnett, and J.P. Atkinson Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes Invest Ophthalmol Vis Sci 50 2009 5818 5827
23. J.M. Seddon, R. Reynolds, and J. Maller Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables Invest Ophthalmol Vis Sci 50 2009 2044 2053
24. J.M. Seddon, R. Reynolds, and Y. Yu Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors Ophthalmology 118 2011 2203 2211
25. K.L. Spencer, L.M. Olson, and N. Schnetz-Boutaud Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration PLoS One [serial online] 6 2011 e17784 Available at: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal. pone.0017784 Accessed July 28, 2013
26. G.S. Ying, M.G. Maguire, and Complications of Age-related Macular Degeneration Prevention Trial Research Group Development of a risk score for geographic atrophy in Complications of the Age-Related Macular Degeneration Prevention Trial Ophthalmology 118 2011 332 338
27. Y. Yu, R. Reynolds, and B. Rosner Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models Invest Ophthalmol Vis Sci 53 2012 1548 1556
28. B. Zanke, S. Hawken, R. Carter, and D. Chow A genetic approach to stratification of risk for age-related macular degeneration Can J Ophthalmol 45 2010 22 27
29. M. Szklo Population-based cohort studies Epidemiol Rev 20 1998 81 90
30. A.C. Janssens, J.P. Ioannidis, and S. Bedrosian Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration Eur J Epidemiol 26 2011 313 337
31. A. Hofman, C.M. van Duijn, and O.H. Franco The Rotterdam Study: 2012 objectives and design update Eur J Epidemiol 26 2011 657 686
32. A. Hofman, D.E. Grobbee, P.T. de Jong, and F.A. van den Ouweland Determinants of disease and disability in the elderly: the Rotterdam Elderly Study Eur J Epidemiol 7 1991 403 422
33. R. Klein, B.E. Klein, K.L. Linton, and D.L. De Mets The Beaver Dam Eye Study: visual acuity Ophthalmology 98 1991 1310 1315
34. P. Mitchell, W. Smith, K. Attebo, and J.J. Wang Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study Ophthalmology 102 1995 1450 1460
35. A.C. Bird, N.M. Bressler, S.B. Bressler International ARM Epidemiological Study Group An international classification and grading system for age-related maculopathy and age-related macular degeneration Surv Ophthalmol 39 1995 367 374
36. R. Klein, M.D. Davis, and Y.L. Magli The Wisconsin Age-Related Maculopathy Grading System Ophthalmology 98 1991 1128 1134
37. Klein R, Meuer SM, Myers CE, et al. Harmonizing the classification of age-related macular degeneration in the Three Continent AMD Consortium. Ophthalmic Epidemiol.
38. AMD Gene Consortium Seven new loci associated with age-related macular degeneration Nat Genet 45 2013 433 439
39. L.J. Kopplin, R.P. Igo Jr., and Y. Wang Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration Genes Immun 11 2010 609 621
40. C.J. Chiu, R.C. Milton, and R. Klein Dietary compound score and risk of age-related macular degeneration in the Age-Related Eye Disease Study Ophthalmology 116 2009 939 946
41. D. Smailhodzic, C.C. Klaver, and B.J. Klevering Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration Ophthalmology 119 2012 339 346
42. E.M. Stone, T.A. Braun, and S.R. Russell Missense variations in the fibulin 5 gene and age-related macular degeneration N Engl J Med 351 2004 346 353
43. J.S. Tan, J.J. Wang, and V. Flood Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study Ophthalmology 115 2008 334 341
44. K.J. Rothman, S. Greenland, T.L. Lash, K.J. Rothman, S. Greenland, and T.L. Lash Modern Epidemiology 3rd ed. 2008 Wolters Kluwer/Lippincott Williams & Wilkins Philadelphia, PA 33
45. J.A. Mares, R.P. Voland, and S.A. Sondel Healthy lifestyles related to subsequent prevalence of age-related macular degeneration Arch Ophthalmol 129 2011 470 480
46. F. Abedi, S. Wickremasinghe, and A.J. Richardson Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration Ophthalmology 120 2013 115 121
47. A. Boltz, M. Ruiß, and J.B. Jonas Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration Ophthalmology 119 2012 1615 1620
48. M.A. Brantley Jr., A.M. Fang, and J.M. King Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab Ophthalmology 114 2007 2168 2173
49. D. Smailhodzic, P.S. Muether, and J. Chen Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration Ophthalmology 119 2012 2304 2311